Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

Research output: Contribution to journalJournal articlepeer-review

Documents

Original languageEnglish
JournalMolecular Oncology
Volume14
Issue number5
Pages (from-to)964-973
ISSN1574-7891
DOIs
Publication statusPublished - 2020

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 238743138